Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacy ; volume:22 ; number:1 ; day:7 ; month:3 ; year:2024 ; pages:1-14 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (7.3.2024), 1-14, 12.2024
- Creator
-
Saffarzadeh, Neshat
Foord, Emelie
O’Leary, Eoghan
Mahmoun, Rand
Birkballe Hansen, Thomas
Levitsky, Victor
Poiret, Thomas
Uhlin, Michael
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-024-05049-2
- URN
-
urn:nbn:de:101:1-2405102112431.733087021914
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Saffarzadeh, Neshat
- Foord, Emelie
- O’Leary, Eoghan
- Mahmoun, Rand
- Birkballe Hansen, Thomas
- Levitsky, Victor
- Poiret, Thomas
- Uhlin, Michael
- SpringerLink (Online service)
Other Objects (12)
Polyclonal tumor-specific activation of cytotoxic effector cells by bispecific antibody constructs
Redirecting oncolytic adenovirus-specific T cells by a tumor-specific T cell receptor for therapy of solid tumors
Development of a highly potent bispecific antibody format targeting the novel tumor-specific antigen CLDN18.2
Tumor‐specific CD 4 + T cells maintain effector and memory tumor‐specific CD 8 + T cells
Neuropilin-1 drives tumor-specific uptake of chlorotoxin
Natural and revolutionary tumor-specific T-cell therapy
Bi-specific Aptamers mediating Tumour Cell Lysis
Sonosynthetic Cyanobacteria Oxygenation for Self‐Enhanced Tumor‐Specific Treatment
Design and Evaluation of Tumor‐Specific Dendrimer Epigenetic Therapeutics
Suppression of tumor-specific immunity by Foxp3+ regulatory T cells
Stimuli‐Responsive Dendritic Supramolecular Vector for Tumor‐Specific Gene Delivery
A tumor-specific endogenous repetitive element is induced by herpesviruses
Polyclonal tumor-specific activation of cytotoxic effector cells by bispecific antibody constructs
Redirecting oncolytic adenovirus-specific T cells by a tumor-specific T cell receptor for therapy of solid tumors
Development of a highly potent bispecific antibody format targeting the novel tumor-specific antigen CLDN18.2
Tumor‐specific CD 4 + T cells maintain effector and memory tumor‐specific CD 8 + T cells
Neuropilin-1 drives tumor-specific uptake of chlorotoxin
Natural and revolutionary tumor-specific T-cell therapy
Bi-specific Aptamers mediating Tumour Cell Lysis
Sonosynthetic Cyanobacteria Oxygenation for Self‐Enhanced Tumor‐Specific Treatment
Design and Evaluation of Tumor‐Specific Dendrimer Epigenetic Therapeutics
Suppression of tumor-specific immunity by Foxp3+ regulatory T cells
Stimuli‐Responsive Dendritic Supramolecular Vector for Tumor‐Specific Gene Delivery
A tumor-specific endogenous repetitive element is induced by herpesviruses
Polyclonal tumor-specific activation of cytotoxic effector cells by bispecific antibody constructs
Redirecting oncolytic adenovirus-specific T cells by a tumor-specific T cell receptor for therapy of solid tumors
Development of a highly potent bispecific antibody format targeting the novel tumor-specific antigen CLDN18.2
Tumor‐specific CD 4 + T cells maintain effector and memory tumor‐specific CD 8 + T cells
Neuropilin-1 drives tumor-specific uptake of chlorotoxin
Natural and revolutionary tumor-specific T-cell therapy
Bi-specific Aptamers mediating Tumour Cell Lysis
Sonosynthetic Cyanobacteria Oxygenation for Self‐Enhanced Tumor‐Specific Treatment
Design and Evaluation of Tumor‐Specific Dendrimer Epigenetic Therapeutics
Suppression of tumor-specific immunity by Foxp3+ regulatory T cells
Stimuli‐Responsive Dendritic Supramolecular Vector for Tumor‐Specific Gene Delivery